S&P 500   4,446.31 (-0.21%)
DOW   34,929.02 (+0.38%)
QQQ   368.88 (-1.19%)
AAPL   145.25 (-1.14%)
MSFT   293.36 (-2.00%)
FB   351.80 (-0.33%)
GOOGL   2,817.21 (-0.95%)
TSLA   792.98 (+2.40%)
AMZN   3,374.00 (-1.50%)
NVDA   215.39 (-2.45%)
BABA   149.10 (+2.77%)
NIO   36.42 (+2.94%)
CGC   14.76 (+6.11%)
GE   106.15 (+2.26%)
MU   75.39 (+1.81%)
AMD   107.29 (+1.41%)
T   27.58 (+1.66%)
F   14.24 (+3.34%)
ACB   6.42 (+7.90%)
DIS   178.60 (+1.48%)
PFE   43.74 (-0.46%)
BA   225.20 (+1.72%)
BAC   43.36 (+2.90%)
S&P 500   4,446.31 (-0.21%)
DOW   34,929.02 (+0.38%)
QQQ   368.88 (-1.19%)
AAPL   145.25 (-1.14%)
MSFT   293.36 (-2.00%)
FB   351.80 (-0.33%)
GOOGL   2,817.21 (-0.95%)
TSLA   792.98 (+2.40%)
AMZN   3,374.00 (-1.50%)
NVDA   215.39 (-2.45%)
BABA   149.10 (+2.77%)
NIO   36.42 (+2.94%)
CGC   14.76 (+6.11%)
GE   106.15 (+2.26%)
MU   75.39 (+1.81%)
AMD   107.29 (+1.41%)
T   27.58 (+1.66%)
F   14.24 (+3.34%)
ACB   6.42 (+7.90%)
DIS   178.60 (+1.48%)
PFE   43.74 (-0.46%)
BA   225.20 (+1.72%)
BAC   43.36 (+2.90%)
S&P 500   4,446.31 (-0.21%)
DOW   34,929.02 (+0.38%)
QQQ   368.88 (-1.19%)
AAPL   145.25 (-1.14%)
MSFT   293.36 (-2.00%)
FB   351.80 (-0.33%)
GOOGL   2,817.21 (-0.95%)
TSLA   792.98 (+2.40%)
AMZN   3,374.00 (-1.50%)
NVDA   215.39 (-2.45%)
BABA   149.10 (+2.77%)
NIO   36.42 (+2.94%)
CGC   14.76 (+6.11%)
GE   106.15 (+2.26%)
MU   75.39 (+1.81%)
AMD   107.29 (+1.41%)
T   27.58 (+1.66%)
F   14.24 (+3.34%)
ACB   6.42 (+7.90%)
DIS   178.60 (+1.48%)
PFE   43.74 (-0.46%)
BA   225.20 (+1.72%)
BAC   43.36 (+2.90%)
S&P 500   4,446.31 (-0.21%)
DOW   34,929.02 (+0.38%)
QQQ   368.88 (-1.19%)
AAPL   145.25 (-1.14%)
MSFT   293.36 (-2.00%)
FB   351.80 (-0.33%)
GOOGL   2,817.21 (-0.95%)
TSLA   792.98 (+2.40%)
AMZN   3,374.00 (-1.50%)
NVDA   215.39 (-2.45%)
BABA   149.10 (+2.77%)
NIO   36.42 (+2.94%)
CGC   14.76 (+6.11%)
GE   106.15 (+2.26%)
MU   75.39 (+1.81%)
AMD   107.29 (+1.41%)
T   27.58 (+1.66%)
F   14.24 (+3.34%)
ACB   6.42 (+7.90%)
DIS   178.60 (+1.48%)
PFE   43.74 (-0.46%)
BA   225.20 (+1.72%)
BAC   43.36 (+2.90%)
NASDAQ:SRCL

Stericycle Stock Forecast, Price & News

$70.16
+0.93 (+1.34 %)
(As of 09/27/2021 01:01 PM ET)
Add
Compare
Today's Range
$69.53
$70.34
50-Day Range
$65.29
$71.30
52-Week Range
$60.11
$79.97
Volume4,719 shs
Average Volume373,616 shs
Market Capitalization$6.44 billion
P/E Ratio292.33
Dividend YieldN/A
Beta1.4
30 days | 90 days | 365 days | Advanced Chart
Receive SRCL News and Ratings via Email

Sign-up to receive the latest news and ratings for Stericycle and its competitors with MarketBeat's FREE daily newsletter.


Stericycle logo

About Stericycle

Stericycle, Inc. engages in the provision of waste management services. It operates through the following segments: North America and International. The North America and International segments offer the following services: Regulated Waste and Compliance Services (RWCS), Secure Information Destruction Services (SID), Communication and Related Services (CRS). The RWCS provides collection and processing of regulated and specialized waste, including medical (including reusable sharps disposal management services), pharmaceutical and hazardous waste, for disposal and compliance programs. The SID provides collection of personal and confidential information for secure destruction and recycling of shredded paper. The CRS includes communication services such as appointment reminders, secure messaging, event registration and other communications for hospitals and IDN's. The company was founded by James W. Sharp in March 1989 and is headquartered in Lake Forest, IL.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Sanitary services
Sub-Industry
Environmental & Facilities Services
Current Symbol
NASDAQ:SRCL
CUSIP
85891210
Employees
15,000
Year Founded
1989

Sales & Book Value

Annual Sales
$2.68 billion
Cash Flow
$4.75 per share
Book Value
$26.59 per share

Profitability

Net Income
$-57,300,000.00

Debt

Price-To-Earnings

Miscellaneous

Market Cap
$6.44 billion
Next Earnings Date
11/4/2021 (Estimated)
Optionable
Optionable

Social Links


MarketRank

Overall MarketRank

1.65 out of 5 stars

Business Services Sector

242nd out of 391 stocks

Sanitary Services Industry

5th out of 8 stocks

Analyst Opinion: 1.1Community Rank: 4.0Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 0.6 5 -4 -3 -2 -1 -












Stericycle (NASDAQ:SRCL) Frequently Asked Questions

Is Stericycle a buy right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Stericycle in the last twelve months. There are currently 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" Stericycle stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SRCL, but not buy additional shares or sell existing shares.
View analyst ratings for Stericycle
or view top-rated stocks.

What stocks does MarketBeat like better than Stericycle?

Wall Street analysts have given Stericycle a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Stericycle wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Stericycle?

Stericycle saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 1,540,000 shares, an increase of 41.3% from the August 15th total of 1,090,000 shares. Based on an average daily trading volume, of 363,100 shares, the short-interest ratio is presently 4.2 days. Approximately 1.7% of the shares of the company are sold short.
View Stericycle's Short Interest
.

When is Stericycle's next earnings date?

Stericycle is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.
View our earnings forecast for Stericycle
.

How were Stericycle's earnings last quarter?

Stericycle, Inc. (NASDAQ:SRCL) released its quarterly earnings results on Friday, August, 6th. The business services provider reported $0.67 earnings per share for the quarter, missing the Zacks' consensus estimate of $0.69 by $0.02. The business services provider earned $672.70 million during the quarter, compared to analysts' expectations of $668.66 million. Stericycle had a trailing twelve-month return on equity of 9.99% and a net margin of 0.86%. The business's quarterly revenue was up 12.5% on a year-over-year basis. During the same period in the prior year, the firm posted $0.46 earnings per share.
View Stericycle's earnings history
.

How has Stericycle's stock price been impacted by COVID-19?

Stericycle's stock was trading at $51.56 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, SRCL stock has increased by 36.0% and is now trading at $70.12.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for SRCL?

4 brokers have issued twelve-month price objectives for Stericycle's shares. Their forecasts range from $74.00 to $76.00. On average, they anticipate Stericycle's stock price to reach $75.00 in the next twelve months. This suggests a possible upside of 7.0% from the stock's current price.
View analysts' price targets for Stericycle
or view top-rated stocks among Wall Street analysts.

Who are Stericycle's key executives?

Stericycle's management team includes the following people:
  • Cindy Jayne Miller, President, CEO, COO & Director
  • Janet H. Zelenka, EVP, Chief Financial & Information Officer
  • Michael S. Weisman, Chief Ethics & Compliance Office & Executive VP
  • Joseph A. Reuter, Chief People Officer & Executive Vice President
  • Stephen Cory White, Chief Commercial Officer & Executive VP

What is Cindy Miller's approval rating as Stericycle's CEO?

132 employees have rated Stericycle CEO Cindy Miller on Glassdoor.com. Cindy Miller has an approval rating of 74% among Stericycle's employees.

What other stocks do shareholders of Stericycle own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Stericycle investors own include The Procter & Gamble (PG), Intel (INTC), NVIDIA (NVDA), Starbucks (SBUX), The Walt Disney (DIS), QUALCOMM (QCOM), Johnson & Johnson (JNJ), AbbVie (ABBV), Fastenal (FAST) and Gilead Sciences (GILD).

What is Stericycle's stock symbol?

Stericycle trades on the NASDAQ under the ticker symbol "SRCL."

Who are Stericycle's major shareholders?

Stericycle's stock is owned by many different institutional and retail investors. Top institutional investors include Vanguard Group Inc. (9.10%), Alliancebernstein L.P. (9.00%), BlackRock Inc. (8.06%), Price T Rowe Associates Inc. MD (7.38%), Baillie Gifford & Co. (5.29%) and Clarkston Capital Partners LLC (4.78%). Company insiders that own Stericycle stock include Daniel Ginnetti, David W Stahl and Stephen Cory White.
View institutional ownership trends for Stericycle
.

Which major investors are selling Stericycle stock?

SRCL stock was sold by a variety of institutional investors in the last quarter, including Alliancebernstein L.P., BlackRock Inc., UBS Asset Management Americas Inc., Credit Suisse AG, Clarkston Capital Partners LLC, Frontier Capital Management Co. LLC, Diamond Hill Capital Management Inc., and Deutsche Bank AG. Company insiders that have sold Stericycle company stock in the last year include Daniel Ginnetti, and Stephen Cory White.
View insider buying and selling activity for Stericycle
or view top insider-selling stocks.

Which major investors are buying Stericycle stock?

SRCL stock was acquired by a variety of institutional investors in the last quarter, including Impax Asset Management Group plc, Mondrian Investment Partners LTD, Nuveen Asset Management LLC, Price T Rowe Associates Inc. MD, State Street Corp, Ensign Peak Advisors Inc, Baillie Gifford & Co., and Bank of Montreal Can.
View insider buying and selling activity for Stericycle
or or view top insider-buying stocks.

How do I buy shares of Stericycle?

Shares of SRCL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Stericycle's stock price today?

One share of SRCL stock can currently be purchased for approximately $70.12.

How much money does Stericycle make?

Stericycle has a market capitalization of $6.43 billion and generates $2.68 billion in revenue each year. The business services provider earns $-57,300,000.00 in net income (profit) each year or $2.25 on an earnings per share basis.

How many employees does Stericycle have?

Stericycle employs 15,000 workers across the globe.

Does Stericycle have any subsidiaries?

The following companies are subsidiares of Stericycle: BFI Medical Waste Inc., Boost GP Acquisition HoldCo LLC, Habitat Ecologico S A, Healthcare Waste Solutions, InQuicker, LiveAnswer, MedServe, Metalchem/DRS BVBA, PSC Environmental Service, SRCL Ireland Limited, SRCL Korea Co. Ltd., Shred-it, Shred-it France, Shred-it GmbH, Shred-it Singapore Pte. Ltd., Shred-it US HoldCo Inc., Stericycle Australia Pty Ltd, Stericycle Communication Solutions Inc., Stericycle Cyprus Ltd, Stericycle Environmental Solutions Inc., Stericycle Espana S.L.U., Stericycle Europe S.a.r.l., Stericycle Gestao Ambiental Ltda., Stericycle International Holdings Limited, Stericycle International LLC, Stericycle Japan Co. Ltd., Stericycle Management LLC, Stericycle Netherlands Holdings B.V., Stericycle Portugal Lda., Stericycle Romania SRL, Stericycle Specialty Waste Solutions Inc., Stericycle ULC, Stericycle of Puerto Rico Inc., and The MPB Group LLC.

When was Stericycle founded?

Stericycle was founded in 1989.

What is Stericycle's official website?

The official website for Stericycle is www.stericycle.com.

Where are Stericycle's headquarters?

Stericycle is headquartered at 2355 WAUKEGAN ROAD, BANNOCKBURN IL, 60015.

How can I contact Stericycle?

Stericycle's mailing address is 2355 WAUKEGAN ROAD, BANNOCKBURN IL, 60015. The business services provider can be reached via phone at (847) 367-5910 or via email at [email protected].


This page was last updated on 9/27/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.